Stream by AlphaSense

Hello! Follow us now, on AlphaSense for all the latest updates and content featuring our Expert Transcript Library and Expert Call Services. Thank you for your support!

#CERAWeek 2024 brought together leaders in the Energy and Industrials sectors to discuss the most pressing economic, regulatory, and geopolitical trends the industries will face this year. Join us next Friday for our Coffee Talk roundtable discussion moderated by Xavier S. where we dig into the key topics from #CERAWeek! Roundtable Experts: Neil Banwart, CFA, [Former] Program Director New Power Business Unit, Cummins Inc. Meha J., Senior Offerings Management - New Energies, Honeywell Prasoon Kumar, [Former] Commercial Director, Offshore Drilling Contractor Key Topics: - Will hydrogen hubs and spokes adoption meet expectations? - How can AI and digital applications improve energy management? - Will excess supply reduce the oil outlook? 📅 Friday, April 5th ⌚ 11 AM ET | 8AM PT | 4PM GMT Register ⤵ https://lnkd.in/gu4Ba3yH

Get up to speed with our latest expert call transcripts from Energy & Industrials, Healthcare, and Tech, Media & Telecom. AlphaSense Expert Transcript Library: 📈 40,000+ on-demand expert call interviews ⚡ Fast, AI-Powered Insights 📱 Mobile app for on-the-go research 📞 Schedule one-on-one calls with experts ✔ Hand-picked buyside interviewers (500+ hours experience) Gain insights on new markets, competitors, and geographies instantly with Expert Insights, the market's leading library of proprietary expert interview transcripts. Learn more ⤵ https://lnkd.in/gBWhPC3a

“One of our AlphaSense experts called AI the grim reaper because it's just so good at catching failures. He went on to say that you may still need 22 projects to get one candidate, but you'll be able to kill the first 21 much earlier.” - Sara Mallatt Stahl, Director of Healthcare Research Watch Sara in this 'Friday Coffee Talk' as she shares her knowledge and domain expertise on current trends in healthcare. Key topics covered: - AI in drug discovery - Update on GLP-1 obesity drugs - Rise of radiotherapeutics - Innovation in AFib: Pulsed Field Ablatio Watch now ⤵ https://lnkd.in/esxg9az6

Join us for an insightful session with Alexia Burland Howard, Senior Analyst at AllianceBernstein, and Sara Mallatt Stahl, Director of Healthcare Research at AlphaSense, as they explore the influence of GLP-1 on consumer behavior. Key Themes: ☑ Analyzing key behavioral and dietary changes in individuals using GLP-1s. ☑ Examining the impact of GLP-1 on different food groups and lifestyle choices, including cooking and eating habits. ☑ Projecting future demand for GLP-1s, manufacturing needs, and the evolution of drug affordability and adherence. ☑ Assessing the potential effects of widespread GLP-1 usage on various sectors within healthcare. 📅 Thursday, March 14th ⌚ 11 AM ET | 8 AM PT | 4 PM GMT Save your spot ⤵ https://lnkd.in/erigQbNB

"Everyone was frothing at the mouth over generative AI. But with good reason, I was just looking at the IDC numbers. And IDC is currently estimating that the global AI software revenue opportunity is $944 billion by 2027. I mean, that's a staggering number." - Michelle Brophy, Director of Technology, Media, and Telecommunications Research In this 'Friday Coffee Talk,' Michelle shares her knowledge and domain expertise on trends in the TMT space. She dives deep, helping to provide valuable perspectives from industry insiders, including former employees, customers, suppliers, and more. Her roundup session included topics (and related companies) like: - Key issues and debates of uptake in Enterprise for #genAI in 2024 - Implications of #genAI for the 2024 semiconductor ecosystem - The rising need for cybersecurity amid digital transformation - Pricing and consumer habit trends in streaming and media Watch now ⤵ https://lnkd.in/eKUAZ_gb

Expert networks bridge informational gaps by connecting investors with subject matter experts, fueling primary investment research. Their insights offer a holistic view, guiding informed decisions. Amidst a saturated market, not all expert networks are equal. Our buyer’s guide highlights key values to consider for tailored investment research. ✅ Powerful AI capabilities to streamline and speed up access to quality experts ✅ Industry-leading compliance to provide content you trust ✅ Quality screened experts, custom vetted for your specific research projects ✅ Industry experts with subject mastery to ensure reliable and valuable insights ✅ Competitive pricing to outperform competitors without the associated costs https://lnkd.in/ex7_mWnJ

Interested in connecting directly with experts from AlphaSense transcripts for deeper insights beyond the text? Our 'Talk to This Expert' feature, available in the AlphaSense expert transcript library, makes it easy. This useful button is embedded within each expert transcript and serves as your direct line to industry-leading minds. With just one click, you can leverage our Expert Call Services to dive deeper, engage in custom one-on-one calls, and gain insights you can’t find anywhere else! Here's what you can gain: 1. Last-Mile Insights – Request clarification on specific topic points to ensure a comprehensive understanding of the expert’s perspective to fill gaps in your investment process. 2. Personalized Answers – Address your burning questions and identify potential red flags with expert insights most relevant to your individual research needs. 3. Fresh Perspectives – Hear the expert’s most recent insights unavailable anywhere else to gain a competitive edge. Learn more: https://lnkd.in/gJmExXS2

Expert Insights: Emerging Enterprise Software GenAI Trends At AlphaSense, we're witnessing the emergence of early success stories in enterprise software, unfolding along two distinct pathways: companies directly benefiting from the application of genAI tasks, and those leveraging genAI to augment their internal product offerings. By tapping into AlphaSense's Expert Insights—a treasure trove of firsthand perspectives culled from our extensive expert transcript library, spanning a breadth of the latest trends and topics—we explore how this innovative form of AI is poised to revolutionize the enterprise landscape! https://lnkd.in/eJhFpu97

Watch reporters Lydia Ramsey Pflanzer, Lizzy Lawrence and Andrew Dunn as they offer an insider's view and share key insights from the J.P. Morgan’s 42nd Annual Healthcare Conference! The panel discussed: - GLP-1 class of drugs for treating type-2 diabetes and obesity - what drugs have been dominating headlines not just in healthcare but also the mainstream media? - Understanding what AI initiatives seem to have real substance vs. just a lot of hype. - Buzz-worthy topics at the conference like cardiovascular/structural heart devices, IPO paperwork being filed, Amazon's work with Omada, and more! Watch now ⤵ https://lnkd.in/ek9JF7fs